Literature DB >> 9625124

Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors.

P L Peghini1, P O Katz, N A Bracy, D O Castell.   

Abstract

OBJECTIVES: It is our experience that many patients treated with proton pump inhibitors (PPI) b.i.d. recover acid secretion during the night. Our aim was to assess the efficacy of omeprazole and lansoprazole b.i.d. on nocturnal gastric acidity.
METHODS: Three groups were studied with intragastric pH monitoring. Group 1 consisted of 17 patients with gastroesophageal reflux disease (GERD) taking omeprazole 20 mg b.i.d. Group 2 was 16 male volunteers taking omeprazole 20 mg b.i.d. and Group 3 comprised 12 volunteers taking lansoprazole 30 mg b.i.d.
RESULTS: The percentages of time that subjects had pH < 4 were lower during supine than upright periods in Groups 1 and 3 (P < 0.01). Recovery of nocturnal acid secretion lasting > 1 h, termed acid breakthrough, occurred in three-fourths of all individuals within 12 h from intake of the evening dose of PPI. Median time to acid breakthrough for the whole group was 7.5 h.
CONCLUSION: Nocturnal acid breakthrough occurs in a majority of patients and normal volunteers taking PPI b.i.d.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9625124     DOI: 10.1111/j.1572-0241.1998.221_a.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  54 in total

1.  Does fasting serum gastrin predict gastric acid suppression in patients on proton-pump inhibitors?

Authors:  E S Bonapace; R S Fisher; H P Parkman
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

Review 2.  Medical treatment of Barrett's esophagus.

Authors:  S J Spechler
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

3.  Endoscopic treatment of gastroesophageal reflux disease--fact or fancy?

Authors:  Jean Paul Galmiche; Jérôme Barouk
Journal:  Curr Gastroenterol Rep       Date:  2002-06

Review 4.  Acid suppression therapy in Barrett's esophagus: the importance of pH monitoring.

Authors:  D O Castell
Journal:  Curr Gastroenterol Rep       Date:  2000-06

Review 5.  The laryngeal and esophageal manifestations of Sjögren's syndrome.

Authors:  Peter C Belafsky; Gregory N Postma
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

Review 6.  Globus pharyngeus: a review of its etiology, diagnosis and treatment.

Authors:  Bong Eun Lee; Gwang Ha Kim
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

7.  Nocturnal acid breakthrough on proton pump inhibitor therapy: to treat or not to treat.

Authors:  Philip O Katz; Robert S Dudnick
Journal:  Curr Treat Options Gastroenterol       Date:  2008-02

8.  Barrett's esophagus and the increasing role of endoluminal therapy.

Authors:  Michael S Smith; Charles J Lightdale
Journal:  Therap Adv Gastroenterol       Date:  2008-09       Impact factor: 4.409

Review 9.  Refractory chronic cough due to gastroesophageal reflux: Definition, mechanism and management.

Authors:  Han-Jing Lv; Zhong-Min Qiu
Journal:  World J Methodol       Date:  2015-09-26

10.  Secretagogue-dependent and -independent transport of zinc hydration forms in rat parietal cells.

Authors:  Florentina Sophie Ferstl; Alice Miriam Kitay; Rebecca Marion Trattnig; Abrar Alsaihati; John Peter Geibel
Journal:  Pflugers Arch       Date:  2016-10-19       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.